Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
CDKN2C mutation
i
Other names:
CDKN2C, Cyclin Dependent Kinase Inhibitor 2C, Cyclin-Dependent Kinase Inhibitor 2C (P18, Inhibits CDK4), Cyclin-Dependent Kinase 4 Inhibitor C, P18-INK6, Cyclin-Dependent Kinase 6 Inhibitor P18, Cyclin-Dependent Kinase 6 Inhibitor, Cyclin-Dependent Inhibitor, CDK6 Inhibitor P18, P18-INK4C, P18-INK4c, INK4C, CDKN6, P18
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
1031
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
CDKN2C mutation
Breast Cancer
CDKN2C mutation
Breast Cancer
ribociclib
Resistant: B - Late Trials
ribociclib
Resistant
:
B
ribociclib
Resistant: B - Late Trials
ribociclib
Resistant
:
B
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.